000			03008nas a22003855i 4500
001			3059-4774
003			DE-He213
005			20260610082541.0
007			cr nn 008mamaa
008			250124s||||||||si uu poo|||||| b|EN |d
022			_a3059-4774
024	7		_a44466 _2local
210	1	0	_aImmun. Inflamm.
245	1	0	_aImmunity & Inflammation _h[electronic resource] / _cedited by Xuetao Cao, Jules Hoffmann.
264		1	_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer.
300			_bonline resource.
520			_aImmunity & Inflammation aims to publish high-quality papers that explore groundbreaking discoveries and insights across the spectrum of immunity and inflammation, from basic science to translational and clinical research. The journal particularly welcomes studies that examine the dual role of inflammation—how appropriate inflammatory responses are essential for initiating and regulating normal immune functions, while dysregulated or excessive inflammation contributes to the pathogenesis of various inflammatory diseases. Topics include, but not limited to: Mediators and regulators in immunity and inflammation (cytokines, inflammasomes, sterile inflammation, immunoaging, neuroinflammation, and inflammation resolution) Immune responses in inflammatory diseases (tumor immunology, autoimmunity, allergies, mucosal immunology, and neuro-immunology) Cell therapy and immunotherapies (immune checkpoint blockade, cytokine therapies, anti-inflammatory drugs, and vaccines) Advanced technologies in immunity (omics, live-cell imaging, gene editing, and synthetic immunology) Through a focus on these areas, Immunity & Inflammation seeks to foster a deeper understanding of inflammation’s role in immunity and promote innovative approaches to prevent and treat inflammation-related diseases. Submissions that delve into the kinetics and dynamics of inflammatory responses—such as the temporal regulation of immune activation and inflammatory resolution, or the spatial interplay of cellular and molecular mediators within tissues—are highly encouraged. The journal is also keen on research addressing inflammation-mediated diseases, conceptual breakthroughs in immune regulation, the development of novel anti-inflammatory drugs, and advances in immune-omics and technologies.
650		0	_aImmunology.
650		0	_aCancer.
650		0	_aInflammation.
650		0	_aImmunotherapy.
650		0	_aImmunology.
650		0	_aBiotechnology.
650	1	4	_aImmunology.
650	2	4	_aCancer Biology.
650	2	4	_aInflammation.
650	2	4	_aImmunotherapy.
650	2	4	_aTranslational Immunology.
650	2	4	_aBiotechnology.
700	1		_aCao, Xuetao. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aHoffmann, Jules. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
856	4	0	_uhttp://link.springer.com/journal/44466 _zOpen Access
999			_c4927 _d4927